HRP20131175T1 - Upotreba kitozana radi ubrzavanja rasta noktiju - Google Patents
Upotreba kitozana radi ubrzavanja rasta noktiju Download PDFInfo
- Publication number
- HRP20131175T1 HRP20131175T1 HRP20131175AT HRP20131175T HRP20131175T1 HR P20131175 T1 HRP20131175 T1 HR P20131175T1 HR P20131175A T HRP20131175A T HR P20131175AT HR P20131175 T HRP20131175 T HR P20131175T HR P20131175 T1 HRP20131175 T1 HR P20131175T1
- Authority
- HR
- Croatia
- Prior art keywords
- nail
- formulation
- accordance
- topical formulation
- intended
- Prior art date
Links
- 229920001661 Chitosan Polymers 0.000 title claims 8
- 230000036562 nail growth Effects 0.000 title 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 9
- 238000009472 formulation Methods 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 208000026721 nail disease Diseases 0.000 claims 2
- 206010003645 Atopy Diseases 0.000 claims 1
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 206010028686 Nail avulsion Diseases 0.000 claims 1
- 206010028698 Nail dystrophy Diseases 0.000 claims 1
- 206010061304 Nail infection Diseases 0.000 claims 1
- 206010028703 Nail psoriasis Diseases 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 230000002682 anti-psoriatic effect Effects 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000036072 healthy nails Effects 0.000 claims 1
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims 1
- 239000003018 immunosuppressive agent Substances 0.000 claims 1
- 229940125721 immunosuppressive agent Drugs 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 238000005728 strengthening Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Claims (9)
1. Topikalna formulacija koja sadrži kitozan, u vodi topljivi kitozan kao aminopolisaharidni derivat, koji se bira između hidroksialkilkitozana i karboksialkilkitozana, i/ili njegove fiziološki prihvatljive soli, u kombinaciji s jednom ili više aktivnih tvari, koje se bira između antipsorijatskih sredstava, imunosupresivnih sredstava, antimikotskih sredstava i/ili sredstava za ojačavanje noktiju, naznačena time što je namijenjena upotrebi u ubrzavanju rasta zdravih noktiju tijekom liječenja bolesti nokta.
2. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 1, naznačena time što navedeni u vodi topljivi kitozan kao aminopolisaharidni derivat ima molekulsku težinu veću od 50000 Da.
3. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 2, naznačena time što navedeni u vodi topljivi kitozan kao aminopolisaharidni derivat ima molekulsku težinu od 100000 do 500000 Da.
4. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 1, naznačena time što je navedeni hidroksialkilkitozan hidroksipropilkitozan.
5. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 1, naznačena time što se navedena bolest nokta bira između infekcije nokta, psorijaze nokta, lišaja nokta, atopičnog dermatitisa nokta, distrofije nokta, te avulzije nokta.
6. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 1, naznačena time što je navedena formulacija lak za nokte, sprej, krema, mast, gel, lozija ili pjena.
7. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 1, naznačena time što je sadržaj kitozana kao aminopolisaharida i/ili njegove soli u navedenoj formulaciji od 0,1 do 10%, težinski, s obzirom na ukupnu težinu formulacije.
8. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 7, naznačena time što je sadržaj kitozana kao aminopolisaharida i/ili njegove soli u navedenoj formulaciji od 0,2 do 5%, težinski, s obzirom na ukupnu težinu formulacije.
9. Topikalna formulacija namijenjena upotrebi u skladu s patentnim zahtjevom 8, naznačena time što je sadržaj kitozana kao aminopolisaharida i/ili njegove soli u navedenoj formulaciji od 0,3 do 2%, težinski, s obzirom na ukupnu težinu formulacije.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07102335A EP1958638A1 (en) | 2007-02-14 | 2007-02-14 | Use of chitosans to increase nail growth rate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20131175T1 true HRP20131175T1 (hr) | 2014-01-17 |
Family
ID=38345983
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110667T HRP20110667T1 (hr) | 2007-02-14 | 2011-09-15 | Upotreba kitozana radi ubrzavanja rasta noktiju |
| HRP20131175AT HRP20131175T1 (hr) | 2007-02-14 | 2013-12-10 | Upotreba kitozana radi ubrzavanja rasta noktiju |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110667T HRP20110667T1 (hr) | 2007-02-14 | 2011-09-15 | Upotreba kitozana radi ubrzavanja rasta noktiju |
Country Status (32)
| Country | Link |
|---|---|
| US (3) | US8680074B2 (hr) |
| EP (3) | EP1958638A1 (hr) |
| JP (3) | JP5426401B2 (hr) |
| KR (2) | KR101131015B1 (hr) |
| CN (2) | CN102988405A (hr) |
| AR (1) | AR065316A1 (hr) |
| AT (1) | ATE522221T1 (hr) |
| AU (1) | AU2008214693B2 (hr) |
| BR (1) | BRPI0807595A2 (hr) |
| CA (1) | CA2677715C (hr) |
| CL (2) | CL2008000444A1 (hr) |
| CO (1) | CO6230979A2 (hr) |
| CY (2) | CY1112058T1 (hr) |
| DK (2) | DK2377541T3 (hr) |
| EA (2) | EA201270116A1 (hr) |
| ES (2) | ES2436647T3 (hr) |
| HK (1) | HK1133189A1 (hr) |
| HR (2) | HRP20110667T1 (hr) |
| IL (1) | IL200269A (hr) |
| MA (1) | MA31236B1 (hr) |
| ME (1) | ME00830B (hr) |
| MX (1) | MX2009008686A (hr) |
| MY (2) | MY163297A (hr) |
| NZ (1) | NZ578896A (hr) |
| PH (1) | PH12014500274A1 (hr) |
| PL (2) | PL2377541T3 (hr) |
| PT (2) | PT2377541E (hr) |
| RS (2) | RS53143B (hr) |
| SI (2) | SI2377541T1 (hr) |
| UA (1) | UA100011C2 (hr) |
| WO (1) | WO2008098869A2 (hr) |
| ZA (1) | ZA200905443B (hr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10201490B2 (en) | 2007-02-14 | 2019-02-12 | Polichem Sa | Use of chitosans for the treatment of nail inflammatory diseases |
| WO2010109423A1 (en) * | 2009-03-25 | 2010-09-30 | Sulur Subramaniam Vanangamudi | A medicinal antifungal and steroids cream comprising chitosan and a process to make it |
| EP2763649A2 (en) * | 2011-10-05 | 2014-08-13 | Allergan, Inc. | Compositions for enhancing nail health |
| PT2793946T (pt) * | 2011-12-20 | 2019-05-08 | Urgo Rech Innovation Et Developpement | Composição tópica filmogénica e uso da mesma para tratar ou prevenir a onicofagia |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| EP2845597A1 (en) * | 2013-09-10 | 2015-03-11 | Polichem S.A. | Hydroxypropyl chitosan for the treatment of onychomycosis |
| EP2910245A1 (en) * | 2014-02-21 | 2015-08-26 | Polichem SA | Topical antifungal composition for treating onychomycosis |
| CN109893472A (zh) * | 2019-04-09 | 2019-06-18 | 涿州皓原箔业有限公司 | 一种环保无毒水性卸甲液及其制备方法 |
| ES2834732B2 (es) * | 2019-12-17 | 2022-03-24 | Univ Valladolid | Solucion acuosa que comprende un complejo de inclusion, metodo de obtencion y su uso para aplicacion en cultivos y la mejora de su rendimiento |
| CN111388416B (zh) * | 2020-02-26 | 2022-03-08 | 浙江康德药业集团股份有限公司 | 一种盐酸利多卡因胶浆剂 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3541305A1 (de) * | 1985-11-22 | 1987-05-27 | Wella Ag | Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung |
| DE3723811A1 (de) * | 1987-07-18 | 1989-01-26 | Wella Ag | Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans |
| CA2008775C (en) * | 1989-02-24 | 1998-12-22 | Alberto Ferro | Nail lacquer |
| EP0615745B1 (en) | 1993-02-19 | 1997-05-02 | Howard Green | Compositions containing corneocyte proteins |
| FR2718637A1 (fr) * | 1994-04-15 | 1995-10-20 | Oreal | Composition cosmétique à appliquer sur l'ongle. |
| RU2108114C1 (ru) * | 1996-12-27 | 1998-04-10 | Товарищество с ограниченной ответственностью Научно-производственное предприятие "Эрлон", Лтд. | Биологическая композиция для лечения ран "коллахит" |
| ITTO980264A1 (it) | 1998-03-26 | 1999-09-26 | Silvio Rossi | Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica |
| US6391334B1 (en) * | 1999-10-25 | 2002-05-21 | Amway Corporation | Barrier-forming composition |
| DE10035991A1 (de) | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
| ATE411032T1 (de) * | 2001-12-14 | 2008-10-15 | Dnp Canada Inc | Verwendungen von chitosanoligosacchariden |
| EP1440683A1 (de) * | 2003-01-23 | 2004-07-28 | Cognis France S.A. | Verwendung von Oligoglucosaminen in kosmetischen oder dermatologischen Zubereitungen |
| EP1491202A1 (en) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
| JP3881992B2 (ja) | 2004-07-30 | 2007-02-14 | シャープ株式会社 | 受信装置、受信プログラム、および受信プログラムを記録した記録媒体 |
| WO2006111426A1 (en) * | 2005-04-19 | 2006-10-26 | Galderma S.A. | Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology |
| FR2892023B1 (fr) * | 2005-10-14 | 2009-09-25 | Galderma Sa | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale |
| DE102006049585A1 (de) * | 2006-10-22 | 2008-04-24 | Susilo, Rudy, Dr. | Nagellack für kosmetische und medizinische Anwendungen |
-
2007
- 2007-02-14 EP EP07102335A patent/EP1958638A1/en not_active Withdrawn
-
2008
- 2008-02-07 SI SI200831116T patent/SI2377541T1/sl unknown
- 2008-02-07 PT PT111723474T patent/PT2377541E/pt unknown
- 2008-02-07 PT PT08716765T patent/PT2117564E/pt unknown
- 2008-02-07 WO PCT/EP2008/051477 patent/WO2008098869A2/en active Application Filing
- 2008-02-07 AT AT08716765T patent/ATE522221T1/de active
- 2008-02-07 KR KR1020097018790A patent/KR101131015B1/ko not_active IP Right Cessation
- 2008-02-07 DK DK11172347.4T patent/DK2377541T3/da active
- 2008-02-07 DK DK08716765.6T patent/DK2117564T3/da active
- 2008-02-07 CA CA2677715A patent/CA2677715C/en not_active Expired - Fee Related
- 2008-02-07 MY MYPI2014000324A patent/MY163297A/en unknown
- 2008-02-07 US US12/449,573 patent/US8680074B2/en not_active Expired - Fee Related
- 2008-02-07 EP EP08716765A patent/EP2117564B1/en active Active
- 2008-02-07 BR BRPI0807595-6A2A patent/BRPI0807595A2/pt not_active IP Right Cessation
- 2008-02-07 CN CN2012102916935A patent/CN102988405A/zh active Pending
- 2008-02-07 CN CN2008800049909A patent/CN101663039B/zh not_active Expired - Fee Related
- 2008-02-07 ES ES11172347.4T patent/ES2436647T3/es active Active
- 2008-02-07 SI SI200830430T patent/SI2117564T1/sl unknown
- 2008-02-07 UA UAA200908419A patent/UA100011C2/ru unknown
- 2008-02-07 PL PL11172347T patent/PL2377541T3/pl unknown
- 2008-02-07 RS RS20130569A patent/RS53143B/en unknown
- 2008-02-07 ES ES08716765T patent/ES2369116T3/es active Active
- 2008-02-07 AU AU2008214693A patent/AU2008214693B2/en not_active Ceased
- 2008-02-07 MY MYPI20093349A patent/MY154499A/en unknown
- 2008-02-07 EA EA201270116A patent/EA201270116A1/ru unknown
- 2008-02-07 EA EA200901093A patent/EA018390B1/ru not_active IP Right Cessation
- 2008-02-07 PL PL08716765T patent/PL2117564T3/pl unknown
- 2008-02-07 NZ NZ578896A patent/NZ578896A/en not_active IP Right Cessation
- 2008-02-07 ZA ZA200905443A patent/ZA200905443B/xx unknown
- 2008-02-07 KR KR1020117012108A patent/KR101323762B1/ko not_active IP Right Cessation
- 2008-02-07 MX MX2009008686A patent/MX2009008686A/es active IP Right Grant
- 2008-02-07 ME MEP-2009-271A patent/ME00830B/me unknown
- 2008-02-07 EP EP11172347.4A patent/EP2377541B1/en active Active
- 2008-02-07 RS RS20110443A patent/RS52031B/en unknown
- 2008-02-07 JP JP2009549395A patent/JP5426401B2/ja not_active Expired - Fee Related
- 2008-02-12 CL CL200800444A patent/CL2008000444A1/es unknown
- 2008-02-12 AR ARP080100602A patent/AR065316A1/es unknown
-
2009
- 2009-08-06 IL IL200269A patent/IL200269A/en not_active IP Right Cessation
- 2009-09-04 MA MA32200A patent/MA31236B1/fr unknown
- 2009-09-14 CO CO09098720A patent/CO6230979A2/es active IP Right Grant
- 2009-12-03 HK HK09111316.5A patent/HK1133189A1/xx not_active IP Right Cessation
-
2011
- 2011-09-15 HR HR20110667T patent/HRP20110667T1/hr unknown
- 2011-11-22 CY CY20111101125T patent/CY1112058T1/el unknown
-
2013
- 2013-07-12 JP JP2013146717A patent/JP2013213048A/ja active Pending
- 2013-07-15 CL CL2013002052A patent/CL2013002052A1/es unknown
- 2013-12-04 CY CY20131101097T patent/CY1115136T1/el unknown
- 2013-12-10 HR HRP20131175AT patent/HRP20131175T1/hr unknown
-
2014
- 2014-01-29 US US14/167,273 patent/US9173827B2/en not_active Expired - Fee Related
- 2014-01-30 PH PH12014500274A patent/PH12014500274A1/en unknown
-
2015
- 2015-08-14 JP JP2015160157A patent/JP6045663B2/ja not_active Expired - Fee Related
- 2015-09-30 US US14/870,684 patent/US20160015620A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20131175T1 (hr) | Upotreba kitozana radi ubrzavanja rasta noktiju | |
| US10016525B2 (en) | Antimicrobial compositions for use in wound care products | |
| JP6964550B2 (ja) | 高レベルの水混和性溶媒を含有する、疎水性物質の実質的に界面活性剤を含まないサブミクロン分散液 | |
| US10208241B2 (en) | Resin coated proppants with antimicrobial additives | |
| US20160032180A1 (en) | Antimicrobial Resin Coated Proppants | |
| AR065317A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
| US11352551B2 (en) | Proppant coatings containing antimicrobial agents | |
| WO2006103037A3 (de) | ZUSAMMENSETZUNG ENTHALTEND β-DEFENSIN 2 | |
| JP2014527079A (ja) | 抗真菌剤の効果を高めるアルギネートオリゴマーの使用 | |
| JP2010533692A5 (hr) | ||
| JP2010518138A5 (hr) | ||
| WO2009016536A3 (en) | Preservative compositions for moist wipes | |
| JP6987039B2 (ja) | 抗菌剤と組み合わせた中極性油の細菌性バイオフィルムに対する相乗的抗菌活性 | |
| CN101977585A (zh) | 局部抗菌组合物 | |
| JP2010518139A5 (hr) | ||
| CN106109259B (zh) | 一种预防汗味的香波沐浴露 | |
| CN102177901B (zh) | 一种含苄索氯铵的防腐杀菌剂组合物及用途 | |
| RU2009139896A (ru) | Композиции по уходу за кожей, содержащие салициловую кислоту | |
| JP2007523137A5 (hr) | ||
| JP2015508790A5 (hr) | ||
| KR102382754B1 (ko) | 미용 발한억제 조성물 | |
| JP6507180B2 (ja) | ボルドおよびセイヨウナツユキソウエキスを含む動物向けの局所組成物およびその使用 | |
| CN106283625A (zh) | 一种用于纺织品的抗菌除臭喷剂 | |
| WO2007082864A3 (en) | Use of chavicol as an antiseptic | |
| CN107753342A (zh) | 一种具有驱蚊效果的保湿喷雾 |